The serum and plasma protein levels of the marker VEGF have often been reported as significantly increased in patients with glioma compared to healthy controls [2, 28, 37, 128, 131], and even higher in patients with metastatic brain lesions [71, 128]. Here, VEGFA is linked to central nervous system cancer.